Pharmabiz12h
Sutro Biopharma & Boehringer Ingelheim BioXcellence collaboration: Established first-in-class cell-free capabilities at commercial scale
Ingelheim, Germany Thursday, January 9, 2025, 15:00 Hrs [IST] ...
Pharmabiz9h
ModeX Therapeutics announces Epstein-Barr virus vaccine candidate enters phase I study in collaboration with Merck
ModeX Therapeutics Inc., an OPKO Health company, announces dosing of the first participant in the phase I study (NCT06655324) of an Epstein-Barr virus (EBV) vaccine candidate being developed in ...
Pharmabiz11h
Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams
Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams: Our Bureau, Bengaluru Thursday, January 9, 2025, 15:30 Hrs [IST] Eli Lilly an ...
Pharmabiz10h
Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel
Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Thursday, January 9, 2025, 17:20 Hrs [IST] Global pharma major Lupin Limited ...
Pharmabiz12h
US FDA clears Solid Biosciences’ IND application for SGT-212 to treat neurologic & cardiac manifestations of Friedreich’s ataxia
Charlestown, Massachusetts Thursday, January 9, 2025, 14:30 Hrs [IST] ...
Pharmabiz11h
US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins
US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins: Shanghai Thursday, January 9, 2025, 1 ...
Pharmabiz14h
Alloy Therapeutics announces target specific collaboration & license agreement for use of AntiClastic Antisense platform with Sanofi for CNS target
Alloy Therapeutics announces target specific collaboration & license agreement for use of AntiClastic Antisense platform with Sanofi for CNS target: Boston, Massachusetts Thursday ...
Pharmabiz13h
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications: San Diego Thursday, January 9, 2025, 14:00 ...
Pharmabiz10h
BlackfinBio acquires Parkinson’s IP patent portfolio from OXB
BlackfinBio acquires Parkinson’s IP patent portfolio from OXB: Sheffield, UK Thursday, January 9, 2025, 17:00 Hrs [IST] BlackfinBio Ltd (BFB), a clinical stage gene therapy comp ...
Pharmabiz15h
Simpson Interventions receives US FDA nod for Acolyte catheter system & 510(k) clearance for its Shadow catheter
Simpson Interventions receives US FDA nod for Acolyte catheter system & 510(k) clearance for its Shadow catheter: Campbell, California Thursday, January 9, 2025, 12:00 Hrs [IST] S ...
Pharmabiz14h
Lupin’s Pithampur Unit-1 facility gets EIR from US FDA with VAI classification
Lupin’s Pithampur Unit-1 facility gets EIR from US FDA with VAI classification: Our Bureau, Mumbai Thursday, January 9, 2025, 12:30 Hrs [IST] Global pharma major Lupin Limited ( ...
Pharmabiz18h
China NMPA approves Astellas Pharma’s Padcev in combination with Keytruda to treat advanced bladder cancer
China NMPA approves Astellas Pharma’s Padcev in combination with Keytruda to treat advanced bladder cancer: Tokyo Thursday, January 9, 2025, 09:00 Hrs [IST] Astellas Pharma Inc.